SESN2 and Insulin resistance: Somewhat expected by the prominent role that AMPK signalling has in counteracting high-glucose-induced damage and insulin resistance, SESN2 might contribute to the amelioration of disorders derived from metabolic syndrome and hyperglycaemia, such as hyperglycaemia-induced glomerular injury [73, 78], hepatosteatosis, and insulin resistance [79].